- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/30 - Composés du cuivre
Détention brevets de la classe A61K 31/30
Brevets de cette classe: 141
Historique des publications depuis 10 ans
|
15
|
14
|
13
|
12
|
9
|
15
|
9
|
8
|
9
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| C Lab Pharma International, S.A. | 15 |
6 |
| CFM Pharma Holding BV | 8 |
5 |
| Distributors Processing, Inc. | 26 |
4 |
| The University of Melbourne | 535 |
4 |
| The Board of Regents of the University of Texas System | 2202 |
4 |
| Novartis AG | 10883 |
3 |
| Nestec S.A. | 2678 |
3 |
| Houn Simon Hsia | 6 |
3 |
| Board of Regents, The University of Texas System | 5754 |
2 |
| The Regents of the University of Michigan | 4676 |
2 |
| Cantex Pharmaceuticals, Inc. | 24 |
2 |
| CDA Research Group, Inc. | 30 |
2 |
| Dr. Bata Zrt. | 7 |
2 |
| Iowa State University Research Foundation, Inc. | 766 |
2 |
| "Ivy Pharm" Limited Liability Company | 4 |
2 |
| Kadmon Pharmaceuticals, LLC | 25 |
2 |
| Meda OTC AB | 31 |
2 |
| Ohio State Innovation Foundation | 2108 |
2 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3131 |
2 |
| Cyprium Therapeutics, Inc. | 5 |
2 |
| Autres propriétaires | 85 |